| P50 | author | Paul L. Greenhaff | Q43153720 |
| P2093 | author name string | Ravi P Mahajan | |
| | Despina Constantin | |
| | Justine McCullough | |
| P2860 | cites work | Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure | Q21144214 |
| | Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting | Q22008491 |
| | Myostatin mutation associated with gross muscle hypertrophy in a child | Q24297666 |
| | Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size | Q24314330 |
| | Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A | Q24314667 |
| | Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy | Q24555065 |
| | Regulation of myostatin activity and muscle growth | Q24555817 |
| | Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways | Q28346530 |
| | Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting | Q28363312 |
| | Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy | Q28582211 |
| | Suppression of body fat accumulation in myostatin-deficient mice | Q28586697 |
| | The effect of exercise on muscle glycogen and electrolytes in normals | Q72799003 |
| | Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle | Q73208228 |
| | Longitudinal changes of biochemical parameters in muscle during critical illness | Q73515746 |
| | Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans | Q73825796 |
| | Tissue protein synthesis rates in critically ill patients | Q74037665 |
| | Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin | Q77793916 |
| | Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes | Q78060401 |
| | Impact of surgical trauma on human skeletal muscle protein synthesis | Q80482024 |
| | Respiratory weakness is associated with limb weakness and delayed weaning in critical illness | Q81251477 |
| | APACHE II: a severity of disease classification system | Q29547729 |
| | Intensive insulin therapy in critically ill patients | Q29618795 |
| | Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy | Q29619282 |
| | Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. | Q33951825 |
| | Paresis acquired in the intensive care unit: a prospective multicenter study | Q34163357 |
| | What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? | Q34343580 |
| | Muscle function in critically ill patients | Q34354969 |
| | Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit | Q34586285 |
| | Regulation of muscle protein synthesis during sepsis and inflammation | Q34628735 |
| | Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. | Q34662451 |
| | Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control | Q35651338 |
| | Regulation of muscle mass by myostatin | Q35912777 |
| | Calpains in muscle wasting. | Q36241898 |
| | Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle | Q36647885 |
| | Calpain activity and muscle wasting in sepsis | Q36956035 |
| | Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. | Q37421047 |
| | Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness | Q37422187 |
| | Intensive care unit-acquired weakness: risk factors and prevention | Q37666324 |
| | Structure to function: muscle failure in critically ill patients. | Q37801761 |
| | Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway | Q40490374 |
| | Regulation of eIF-4E BP1 phosphorylation by mTOR. | Q41087062 |
| | Protein Turnover, Synthesis and Breakdown before and after Recovery from Protein-Energy Malnutrition | Q41347955 |
| | Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle | Q42532366 |
| | Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. | Q42817477 |
| | Altered protein kinetics in vivo after single-limb burn injury | Q42848334 |
| | Necrotizing myopathy in critically-ill patients | Q44440526 |
| | Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. | Q44844832 |
| | A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. | Q46346112 |
| | Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle | Q46359311 |
| | Acquired weakness, handgrip strength, and mortality in critically ill patients | Q48433888 |
| | Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism | Q51805331 |
| | Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality | Q51809075 |
| | Metabolism in peripheral tissues in cancer patients. | Q54542943 |
| | Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm | Q57790468 |
| | Human Septic Myopathy: Induction of Cyclooxygenase, Heme Oxygenase and Activation of the Ubiquitin Proteolytic Pathway | Q59650782 |
| | PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle | Q60730463 |
| | Cathepsin B and D activity in human skeletal muscle in disease states | Q67249528 |
| | A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes | Q71032735 |
| | Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma | Q71694941 |
| | The local and systemic effects of minor injury on muscle protein synthesis in the rat | Q71801541 |
| P433 | issue | Pt 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 3883-3895 | |
| P577 | publication date | 2011-06-13 | |
| P1433 | published in | Journal of Physiology | Q7743612 |
| P1476 | title | Novel events in the molecular regulation of muscle mass in critically ill patients. | |
| P478 | volume | 589 | |